Wednesday, April 25, 2012

From Tohoku U: Parkinson's disease and mesenchymal stem cells: potential for cell-based therapy

http://www.ncbi.nlm.nih.gov/pubmed/22530164


Parkinsons Dis. 2012;2012:873706. Epub 2012 Feb 28.

Parkinson's disease and mesenchymal stem cells: potential for cell-based therapy.

Source

Department of Stem Cell Biology and Histology, Tohoku University Graduate School of Medicine, Sendai 980-8575, Japan.

Abstract

Cell transplantation is a strategy with great potential for the treatment of Parkinson's disease, and many types of stem cells, including neural stem cells and embryonic stem cells, are considered candidates for transplantation therapy. Mesenchymal stem cells are a great therapeutic cell source because they are easy accessible and can be expanded from patients or donor mesenchymal tissues without posing serious ethical and technical problems. They have trophic effects for protecting damaged tissues as well as differentiation ability to generate a broad spectrum of cells, including dopamine neurons, which contribute to the replenishment of lost cells in Parkinson's disease. This paper focuses mainly on the potential of mesenchymal stem cells as a therapeutic cell source and discusses their potential clinical application in Parkinson's disease.

No comments:

Post a Comment